DiAL Health Research Study

Sponsor
Pennington Biomedical Research Center (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05549362
Collaborator
(none)
90
5
23.2

Study Details

Study Description

Brief Summary

The purpose of this study is to conduct a five-arm pilot and feasibility trial in healthy, young individuals without obesity to evaluate the feasibility and efficacy of dietary intervention approaches to slow mechanisms of aging.

Condition or Disease Intervention/Treatment Phase
  • Other: Dial Health Research Study
N/A

Detailed Description

Nutritional interventions are one of the most promising non-pharmacological approaches that attenuate aging. Continuous calorie restriction (CR), the most studied intervention, extends lifespan in animals and, in humans, slows biological aging and improves healthspan (e.g., disease risk factors, quality of life). In the largest clinical trial of CR in humans (CALERIE 2), adherence to 25% CR waned to ~12% CR over 2 years, which questions the practicality of such interventions over longer periods. CALERIE 2, however, did not benefit from a more advanced approach, namely a Just-in-Time Adaptive Intervention (JITAI), which tailors and optimizes the intervention for each subject. JITAIs strive to provide individuals with the right type and amount of personalized support when necessary by adapting the intervention delivery to the present adherence, needs and environment of the subject. This is accomplished by the use of mobile health (mHealth) technology (smartphones, sensors) to objectively evaluate intervention adherence in real-time and to adapt intervention delivery to each individual over time. The near real-time collection of ecologically valid and objective data from people in their free-living environment dramatically improves the ability to promote adherence and subject engagement.

Newer approaches, such as time-restricted eating (TRE), where food intake is restricted to less than a 10-hour period of the day, may also benefit aging. Short-term pilot studies of TRE showed that, independent of CR, eating over a 6-hour window that began in the morning significantly improved diabetes and cardiovascular risk factors (healthspan) and biomarkers of primary aging (e.g., autophagy, oxidative stress, nutrient sensing). The long-term feasibility of TRE is unknown, and it is unclear if TRE interventions with JITAI designs enhance intervention feasibility and adherence in the context of healthy aging.

The current trial will examine the feasibility and preliminary efficacy of two CR and two TRE interventions to modulate healthspan and biomarkers of aging in healthy, young (25-45 years) individuals. In a 5-arm pilot and feasibility trial, 90 people without obesity (BMI 22-29.9 kg/m2) will be randomized to either ad libitum Control, Traditional CR, Adaptive CR, Traditional TRE, or Adaptive TRE for 24 weeks (n=18/group) for six months

Study Design

Study Type:
Interventional
Anticipated Enrollment :
90 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double (Investigator, Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Dietary Approaches to Longevity and Health
Anticipated Study Start Date :
Sep 26, 2022
Anticipated Primary Completion Date :
Dec 31, 2023
Anticipated Study Completion Date :
Aug 31, 2024

Arms and Interventions

Arm Intervention/Treatment
Placebo Comparator: ad libitum Control

No treatment control condition.

Other: Dial Health Research Study
To evaluate the feasibility and efficacy of dietary intervention approaches to slow mechanisms of aging.

Active Comparator: Traditional CR

A 25% calorie restriction (CR) intervention delivered via traditional in-person sessions.

Other: Dial Health Research Study
To evaluate the feasibility and efficacy of dietary intervention approaches to slow mechanisms of aging.

Active Comparator: Adaptive CR

A 25% calorie restriction (CR) intervention delivered via a remote, adaptive, and technology-driven intervention program.

Other: Dial Health Research Study
To evaluate the feasibility and efficacy of dietary intervention approaches to slow mechanisms of aging.

Active Comparator: Traditional TRE

An eight-hour time restricted eating (TRE) intervention delivered via traditional in-person sessions.

Other: Dial Health Research Study
To evaluate the feasibility and efficacy of dietary intervention approaches to slow mechanisms of aging.

Active Comparator: Adaptive TRE

An eight-hour time restricted eating (TRE) intervention delivered via a remote, adaptive, and technology driven intervention program.

Other: Dial Health Research Study
To evaluate the feasibility and efficacy of dietary intervention approaches to slow mechanisms of aging.

Outcome Measures

Primary Outcome Measures

  1. Intervention satisfaction ratings [6 months]

    Intervention satisfaction will be assessed via Likert ratings for each study group.

  2. Percent CR (CR groups only) [6 months]

    Percent calorie restriction (CR) will be quantified for the 2 CR groups via doubly labeled water and the intake balance method.

  3. Percent adherence to TRE (TRE groups only) [10 days over at least 3 timepoints]

    Percent adherence to the eating window in the time-restricted eating groups will be assessed by continuous glucose monitoring.

Eligibility Criteria

Criteria

Ages Eligible for Study:
25 Years to 45 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  1. Healthy male or non-pregnant pre-menopausal female, 25-45 years of age, inclusive

  2. BMI ≥22kg/m2 and <30kg/m2

  3. Screening lab values within normal limits, or deemed not clinically significant

  4. Stable body weight (less than ± 2kg) in the past 6 months

  5. Regularly wake up between 5-8 AM

Exclusion Criteria

  1. History of prior bariatric surgery, active gallstone disease, extensive bowel resection or any disease or condition that seriously affects body weight and/or body composition

  2. Regular (daily) use of medications for chronic medical conditions.

  3. History or clinical manifestation of:

  4. Significant chronic metabolic, hematologic, pulmonary, cardiovascular, gastrointestinal, neurologic, immune, hepatic, renal, urologic, circadian, sleep disorders, reproduction or other condition that would not be considered 'healthy' in opinion of the investigator

  5. Anemia (Hb <10 g/dL or hematocrit < 30)

  6. Diabetes or fasting glucose ≥ 126 mg/dL or HbA1c ≥ 6.5% at screening

  7. Hypertension (Systolic Blood Pressure >140 mmHg & Diastolic Blood Pressure >90 mmHg)

  8. Cancer requiring treatment in the past 5 years (except for non-melanoma skin cancer)

  9. Low Bone mineral density z-score < -2.0 of the hip (total hip or femoral neck) or lumbar spine (L1-L4)

  10. Depression as determined by the Beck Depression Inventory-II > 19

  11. Pregnant, postpartum (< 12 months) or lactating females or attempting to become pregnant in the next 7 months

  12. Current or history (within the past 5 years) of an eating disorder

  13. Asthma or sleep apnea

  14. Lifestyle related factors that would confound outcomes:

  15. Non-conventional eating patterns (vegan, paleo, fasting, etc.) and eating duration (<11 hours per day)

  16. Drug or alcohol abuse (up to 14 drinks a week are allowed) within the past 2 years

  17. Current smoking, vaping or use of tobacco products within the past 6 months

  18. Currently participating or recently engaged (4 consecutive weeks in the past 3 months) in heavy aerobic activity (e.g., jogging, running, or riding fast on a bicycle) ≥ 240 minutes per week or heavy resistance training ≥ 3 times per week that results in heavy breathing and sweating.

  19. Perform overnight shift work > 1 day/week or plan to cross more than 2 time zones within 1 month of study assessments

  20. Unwilling or unable to adhere to the rigors of the protocol or failure to complete the behavioral run-in task (at least 80% compliance)

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • Pennington Biomedical Research Center

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Corby K. Martin, Professor, Pennington Biomedical Research Center
ClinicalTrials.gov Identifier:
NCT05549362
Other Study ID Numbers:
  • PBRC 2021-020
First Posted:
Sep 22, 2022
Last Update Posted:
Sep 23, 2022
Last Verified:
Sep 1, 2022
Individual Participant Data (IPD) Sharing Statement:
Yes
Plan to Share IPD:
Yes
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Sep 23, 2022